Michael J. Ambrogi, Chief Operating Officer at NovoCure Ltd (NVCR), sold 116,623 shares at $70.99 ($8.2M) on 2020-04-14, disclosed to the SEC on 2020-04-15.
Open-market sale of $8.2M NVCR by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $69.01 | 22,755 | $1.6M | 19.2% |
| 2 | $69.01 | 22,755 | $1.6M | 19.2% |
| 3 | $70.18 | 8,226 | $577K | 7.1% |
| 4 | $70.18 | 8,226 | $577K | 7.1% |
| 5 | $70.99 | 27,142 | $1.9M | 23.6% |
| 6 | $70.99 | 27,142 |
| $1.9M |
| 23.6% |
| 7 | $71.75 | 377 | $27K | 0.3% |
| Total | $70.11 avg | 116,623 | $8.2M | 100% |
| Filing → |
| NVCR | SELL | 2020-03-02 | $386K | — | Filing → |
| NVCR | SELL | 2020-02-26 | $1.9M | — | Filing → |
| NVCR | SELL | 2019-11-06 | $6.4M | — | Filing → |